Bellerophon Therapeutics, Inc.·4

Nov 19, 4:36 PM ET

Tenenbaum Fabian 4

4 · Bellerophon Therapeutics, Inc. · Filed Nov 19, 2019

Insider Transaction Report

Form 4
Period: 2019-11-15
Tenenbaum Fabian
Chief Executive Officer
Transactions
  • Tax Payment

    Common Stock

    2019-11-15$0.34/sh76,823$26,120407,459 total

Documents

1 file
  • 4
    wf-form4_157419935334132.xmlPrimary

    FORM 4